Pharma-Bio Serv, Inc.
Other OTCTotal Valuation
Pharma-Bio Serv, Inc. carries a market capitalization of 10.99M, placing it among publicly traded companies globally. Its enterprise value stands at 1.04M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 10.99M |
| Enterprise Value | 1.04M |
Share Statistics
Pharma-Bio Serv, Inc. currently has 22.90M shares outstanding.
| Shares Outstanding | 22.90M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Pharma-Bio Serv, Inc. trades at a trailing price-to-earnings ratio of 38.24. The price-to-sales ratio is 1.01, and the price-to-book ratio stands at 0.92.
| PE Ratio | 38.24 |
| PS Ratio | 1.01 |
| PB Ratio | 0.92 |
| P/TBV Ratio | 0.92 |
| P/FCF Ratio | -23.56 |
| P/OCF Ratio | -23.19 |
Enterprise Valuation
| EV / Sales | 0.11 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Pharma-Bio Serv, Inc. maintains a current ratio of 11.30, meaning it holds 11.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 11.30 |
| Quick Ratio | 11.06 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
Pharma-Bio Serv, Inc. posts a return on equity of 2.25 and a return on invested capital of -2.30.
| Return on Equity (ROE) | 2.25 |
| Return on Assets (ROA) | 2.01 |
| Return on Invested Capital (ROIC) | -2.30 |
| Return on Capital Employed (ROCE) | 2.24 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Pharma-Bio Serv, Inc. has paid 17,474.00 in income taxes, reflecting an effective tax rate of 6.50.
| Income Tax | 17,474.00 |
| Effective Tax Rate | 6.50 |
Stock Price Statistics
Pharma-Bio Serv, Inc.'s stock has declined approximately -25% over the past 52 weeks. The 50-day moving average sits at 0.48, while the 200-day moving average is 0.52.
| Beta (5Y) | N/A |
| 52-Week Price Change | -25% |
| 50-Day Moving Average | 0.48 |
| 200-Day Moving Average | 0.52 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Pharma-Bio Serv, Inc. generated 9.48M in revenue and converted that into 251,525.00 in net income, yielding earnings per share of 0.01. EBITDA reached -24,258.00, while operating income came in at -154,943.00.
| Revenue | 9.48M |
| Gross Profit | 3.07M |
| Operating Income | -154,943.00 |
| Pretax Income | 268,999.00 |
| Net Income | 251,525.00 |
| EBITDA | -24,258.00 |
| EBIT | -154,943.00 |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
Total book value stands at 10.44M, with working capital of 10.24M providing operational flexibility.
| Cash & Cash Equivalents | 8.58M |
| Total Debt | N/A |
| Net Debt | -1.52M |
| Equity (Book Value) | 10.44M |
| Book Value Per Share | 0.46 |
| Working Capital | 10.24M |
Cash Flow
Pharma-Bio Serv, Inc. produced -414,892.00 in operating cash flow over the past twelve months. After subtracting -6,472.00 in capital expenditures, free cash flow totaled -421,364.00 - equivalent to -0.02 per share.
| Operating Cash Flow | -414,892.00 |
| Capital Expenditures | -6,472.00 |
| Free Cash Flow | -421,364.00 |
| FCF Per Share | -0.02 |
Margins
Pharma-Bio Serv, Inc. operates with a gross margin of 32.32, reflecting its pricing power and cost economics. The operating margin of -1.63 and net profit margin of 2.65 provide insight into operational efficiency.
| Gross Margin | 32.32 |
| Operating Margin | -1.63 |
| Pretax Margin | 2.84 |
| Profit Margin | 2.65 |
| EBITDA Margin | -0.26 |
Dividends & Yields
The company's payout ratio of 682.89 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.07 |
| Dividend Yield | N/A |
| Payout Ratio | 682.89 |
| Shareholder Yield | 17.98 |
| FCF Yield | -4.24 |
Scores
Pharma-Bio Serv, Inc. posts an Altman Z-Score of 8.77, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 8.77 |